Pulmonary Medicine

Episodes 33-43 of 43

• 

  RestartResume

  Professional Recommendations of Clinically Validated Tools Used to Monitor Response to Treatment in Idiopathic Hypersomnia

  RestartResume

  Professional Recommendations of Clinically Validated Tools Used to Monitor Response to Treatment in Idiopathic Hypersomnia

  MinuteCE®

  Professional Recommendations of Clinically Validated Tools Used to Monitor Response to Treatment in Idiopathic Hypersomnia

  1.00 program credit

  • 

    

    Matthew Davis, MD

  • 

    

    Alcibiades J. Rodriguez, MD, FAASM

  1.00 program credit

• 

  RestartResume

  Challenges in Recognizing and Diagnosing Narcolepsy

  RestartResume

  Challenges in Recognizing and Diagnosing Narcolepsy

  MinuteCE®

  Challenges in Recognizing and Diagnosing Narcolepsy

  1.00 program credit

  • 

    Kevin Trice, MD

  1.00 program credit

• 

  RestartResume

  Evaluating and Promoting Health in Idiopathic Hypersomnia: Beyond Sleepy

  RestartResume

  Evaluating and Promoting Health in Idiopathic Hypersomnia: Beyond Sleepy

  MinuteCE®

  Evaluating and Promoting Health in Idiopathic Hypersomnia: Beyond Sleepy

  1.00 program credit

  • 

    

    Logan Schneider, MD

  1.00 program credit

• 

  RestartResume

  Expert Consensus on How Oxybates Influence Cardiovascular Risk in Narcolepsy Patients

  RestartResume

  Expert Consensus on How Oxybates Influence Cardiovascular Risk in Narcolepsy Patients

  MinuteCE®

  Expert Consensus on How Oxybates Influence Cardiovascular Risk in Narcolepsy Patients

  1.00 program credit

  • 

    Kevin Trice, MD

  • 

    

    Lee Surkin, MD, FACC, FCCP, FASNC, FAASM

  1.00 program credit

• 

  RestartResume

  Treatment Options for the Management of Narcolepsy

  RestartResume

  Treatment Options for the Management of Narcolepsy

  MinuteCE®

  Treatment Options for the Management of Narcolepsy

  1.00 program credit

  • 

    

    Ana C. Krieger, MD

  1.00 program credit

• 

  RestartResume

  Idiopathic Hypersomnia and Cardiovascular Health: Too Much of a Good Thing?

  RestartResume

  Idiopathic Hypersomnia and Cardiovascular Health: Too Much of a Good Thing?

  MinuteCE®

  Idiopathic Hypersomnia and Cardiovascular Health: Too Much of a Good Thing?

  1.00 program credit

  • 

    

    Logan Schneider, MD

  1.00 program credit

• 

  RestartResume

  Challenges in Recognizing and Diagnosing Idiopathic Hypersomnia

  RestartResume

  Challenges in Recognizing and Diagnosing Idiopathic Hypersomnia

  MinuteCE®

  Challenges in Recognizing and Diagnosing Idiopathic Hypersomnia

  1.00 program credit

  • 

    

    Alcibiades J. Rodriguez, MD, FAASM

  1.00 program credit

• 

  RestartResume

  Evidence-based Discussion of the New and Emerging Treatment Strategies for Idiopathic Hypersomnia

  RestartResume

  Evidence-based Discussion of the New and Emerging Treatment Strategies for Idiopathic Hypersomnia

  MinuteCE®

  Evidence-based Discussion of the New and Emerging Treatment Strategies for Idiopathic Hypersomnia

  1.00 program credit

  • 

    

    Matthew Davis, MD

  • 

    

    Logan Schneider, MD

  1.00 program credit

• 

  RestartResume

  Idiopathic Hypersomnia Insights: A Diagnostic Case Study

  RestartResume

  Idiopathic Hypersomnia Insights: A Diagnostic Case Study

  MinuteCE®

  Idiopathic Hypersomnia Insights: A Diagnostic Case Study

  1.00 program credit

  • 

    

    Alcibiades J. Rodriguez, MD, FAASM

  1.00 program credit

• 

  RestartResume

  Practical Approach to Incorporation of Oxybates Into Clinical Practice

  RestartResume

  Practical Approach to Incorporation of Oxybates Into Clinical Practice

  MinuteCE®

  Practical Approach to Incorporation of Oxybates Into Clinical Practice

  1.00 program credit

  • 

    Kevin Trice, MD

  • 

    

    Ana C. Krieger, MD

  1.00 program credit

• 

  RestartResume

  Case: Clinical Features of Narcolepsy

  RestartResume

  Case: Clinical Features of Narcolepsy

  MinuteCE®

  Case: Clinical Features of Narcolepsy

  1.00 program credit

  • 

    

    Ana C. Krieger, MD

  1.00 program credit